Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.17 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.25.1.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.409NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.83NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.310NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.362.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.162NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Y.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.86NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.154NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.4.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.137NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.446NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.76 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.398NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.163NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.3 (Theta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.38.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAVNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.4.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.77NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.60NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.9.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.15 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.75.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.134NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.2 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
M.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.82 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used